rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2009-6-2
|
pubmed:abstractText |
Systemic administration of corticosteroid, plasmapheresis and high-dose immunoglobulin therapy (IVIG) are the main treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
|
pubmed:language |
jpn
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0021-4884
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
537-47
|
pubmed:meshHeading |
pubmed-meshheading:19487835-Adult,
pubmed-meshheading:19487835-Aged,
pubmed-meshheading:19487835-Aged, 80 and over,
pubmed-meshheading:19487835-Epidermal Necrolysis, Toxic,
pubmed-meshheading:19487835-Female,
pubmed-meshheading:19487835-Glucocorticoids,
pubmed-meshheading:19487835-Humans,
pubmed-meshheading:19487835-Immunoglobulins,
pubmed-meshheading:19487835-Male,
pubmed-meshheading:19487835-Methylprednisolone,
pubmed-meshheading:19487835-Middle Aged,
pubmed-meshheading:19487835-Plasma Exchange,
pubmed-meshheading:19487835-Prognosis,
pubmed-meshheading:19487835-Pulse Therapy, Drug,
pubmed-meshheading:19487835-Stevens-Johnson Syndrome
|
pubmed:year |
2009
|
pubmed:articleTitle |
[Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
|
pubmed:affiliation |
Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Japan. yumiko@dream.design.co.jp
|
pubmed:publicationType |
Journal Article,
English Abstract
|